A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 126-135

  Mendel, Itzhak ^a   Shoham, Anat ^a   Propheta Meiran, Oshrat ^a   Ishai, Eti ^a   Halperin, Gideon ^a   Feige, Erez ^a   Breitbart, Eyal ^a  

^a VBL Therapeutics   (Israel)

Author keywords

Experimental autoimmune encephalomyelitis; Oxidized phospholipids; T cells

Indexed keywords

1 HEXADECYL 2 (4' CARBOXY)BUTYLGLYCERO 3 PHOSPHOCHOLINE; LECINOXOID; LECINOXOIDS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG; VB 201; BROXURIDINE; CD4 ANTIGEN; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; FREUND ADJUVANT; GLYCEROPHOSPHORYLCHOLINE; GLYCOPROTEIN; IONOMYCIN; IONOPHORE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; PERTUSSIS TOXIN; PHOSPHORYLCHOLINE; POLY(MPC-CO-MA); POLYMETHACRYLIC ACID DERIVATIVE; VB-201;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; IN VIVO STUDY; LIPID OXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CHEMISTRY; COMPLICATION; DENDRITIC CELL; DISEASE MODEL; DRUG EFFECTS; DRUG INTERACTION; ENCEPHALITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LYMPH NODE; METABOLISM; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TIME;

ANIMALS; ANTIGENS, CD4; BONE MARROW CELLS; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENCEPHALITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; FREUND'S ADJUVANT; GLYCERYLPHOSPHORYLCHOLINE; GLYCOPROTEINS; IONOMYCIN; IONOPHORES; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PHOSPHORYLCHOLINE; POLYMETHACRYLIC ACIDS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TIME FACTORS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN;

EID: 77956340243     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.011     Document Type: Article

References (29)

1. Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 2002, 110:493-497.
2. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 1990, 85:1260-1266.
3. Blüml S., Kirchberger S., Bochkov V.N., Kronke G., Stuhlmeier K., Majdic O., Zlabinger G.J., Knapp W., Binder B.R., Stöckl J., Leitinger N. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J. Immunol. 2005, 175:501-508.
4. Bochkov V.N., Kadl A., Huber J., Gruber F., Binder B.R., Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002, 419:77-81.
5. Boullier A., Gillotte K.L., Horkko S., Green S.R., Friedman P., Dennis E.A., Witztum J.L., Steinberg D., Quehenberger O. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 2000, 275:9163-9169.
6. Brok H.P., van Meurs M., Blezer E., Schantz A., Peritt D., Treacy G., Laman J.D., Bauer J., 't Hart B.A. Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. J. Immunol. 2002, 169:6554-6563.
7. Chang M.K., Binder C.J., Miller Y.I., Subbanagounder G., Silverman G.J., Berliner J.A., Witztum J.L. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 2004, 200:1359-1370.
8. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
9. Faria A.M., Weiner H.L. Oral tolerance. Immunol. Rev. 2005, 206:232-269.
10. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002, 169:7104-7110.
11. Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 1988, 140:440-445.
12. Horkko S., Bird D.A., Miller E., Itabe H., Leitinger N., Subbanagounder G., Berliner J.A., Friedman P., Dennis E.A., Curtiss L.K., Palinski W., Witztum J.L. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 1999, 103:117-128.
13. Izikson L., Klein R.S., Charo I.F., Weiner H.L., Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 2000, 192:1075-1080.
14. Kanter J.L., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., Steinman L., Robinson W.H. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 2006, 12:138-143.
15. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., Hama S., Borromeo C., Evans R.M., Berliner J.A., Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 2000, 87:516-521.
16. Lucas M., Stuart L.M., Savill J., Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 2003, 171:2610-2615.
17. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., Cua D.J. Divergent pro- and anti inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003, 198:1951-1957.
18. Naidoo R., Knapp M.L. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin. Chem. 1992, 38:2449-2454.
19. Nicoletti A., Caligiuri G., Tornberg I., Kodama T., Stemme S., Hansson G.K. The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur. J. Immunol. 1999, 29:512-521.
20. Nonas S., Miller I., Kawkitinarong K., Chatchavalvanich S., Gorshkova I., Bochkov V.N., Leitinger N., Natarajan V., Garcia J.G., Birukov K.G. Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am. J. Respir. Crit. Care Med. 2006, 173:1130-1138.
21. Qin J., Goswami R., Balabanov R., Dawson G. Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J. Neurosci. Res. 2007, 85:977-984.
22. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998, 187:537-546.
23. Seyerl M., Blüml S., Kirchberger S., Bochkov V.N., Oskolkova O., Majdic O., Stöckl J. Oxidized phospholipids induce anergy in human peripheral blood T cells. Eur. J. Immunol. 2008, 38:778-787.
24. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320:915-924.
25. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., Khoury J.E., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
26. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337-342.
27. Subbanagounder G., Leitinger N., Schwenke D.C., Wong J.W., Lee H., Rizza C., Watson A.D., Faull K.F., Fogelman A.M., Berliner J.A. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2248-2254.
28. Teitelbaum D., Arnon R., Sela M. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc. Natl. Acad. Sci. 1999, 96:3842-3847.
29. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992, 356:63-66.